Agenus Inc / Aandelenkoers
7,42 +0,96 (14,86%)
Nabeurs: 7,42 +0,00 (0,00%)
AGEN(NASDAQ)
24 apr, 4:00 p.m. EDT · Valuta in USD · Disclaimer
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
Meer om te vragen
Is AGEN a good stock to buy?
What kind of company is Agenus?
Who owns AGEN stock?
What is the stock price forecast for Agenus in 2025?
AGEN | Complete Agenus Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Mensen zoeken ook naar
Discover real-time Agenus Inc. Common Stock (AGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients.
13 apr 2024 · ("Agenus") (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the ...
The commune of Agen is the prefecture of the Lot-et-Garonne department in Nouvelle-Aquitaine, southwestern France. It lies on the river Garonne 135 ...
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents.
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its ...
Complete Agenus Inc. stock information by Barron's. View real-time AGEN stock price and news, along with industry-best analysis.